Palatal actinomycosis osteomyelitis–Complication of impacted tooth in a diabetic

Agarwal, Padmanidhi; Chug, Ashi; Kumar, Shailesh; Jain, Kanika

doi:10.1111/scd.12371

Cited by 5 publications

(10 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to the decreased vascular supply, the penetration of antibiotics in actinomycosis is also significantly reduced, which explains the need for surgical excision of the lesion and long-term antibiotic coverage, thus demonstrating the correlation of the treatment of osteonecrosis induced by bisphosphonates (Agarwal et al, 2019;Haggerty & Tender, 2012). Some authors discuss the need for removal of bisphosphonates in patients who have progressed with osteonecrosis to help in the treatment of the pathology, not observing a great improvement in the clinical conditions due to the high rate of bioavailability of the medication (Dimitrakopoulos & Magopoulos, 2006;Migliorati et al, 2005;Senturk et al, 2017).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Medication-induced osteonecrosis of the maxilla, potentiated by fungical infection: Case report

Collini¹,

Pulino²,

Collini³

et al. 2023

EACAD

View full text Add to dashboard Cite

Osteonecrosis of the jaws induced using bisphosphonates refers to a condition characterized by the exposure of necrotic bone, usually in the face region and commonly originating from trauma. Osteonecrosis induced by bisphosphonates has its highest prevalence in the mandible and may be initially manifested by ulcerations in the oral mucosa, which expose the underlying bone due to its poor vascularization and the use of bisphosphonates. Bisphosphonates are indicated for the treatment of several comorbidities, such as malignant tumors, bone metastases, osteoporosis. Actinomycosis is rarely a pathological concern due to the low virulence of the organism, but it can manifest itself when associated with other pathologies such as osteonecrosis. The clinical case presents a patient who made prolonged use of bisphosphonates associated with low-intensity trauma evolving to maxillary osteonecrosis potentiated by actnomyses. This article aims to demonstrate the connection between actinomycosis and chronic osteonecrosis and the importance of correct diagnosis for correct treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Comorbidities such as immunosuppression, osteoradionecrosis, osteonecrosis induced by medication and leukemia are systemic factors that favor infections by actinomyces mainly in patients with lesions in the oral mucosa (Agarwal et al, 2019;McCann et al, 2019).…”

Section: Introductionmentioning

confidence: 99%

Medication-induced osteonecrosis of the maxilla, potentiated by fungical infection: Case report

Collini¹,

Pulino²,

Collini³

et al. 2023

EACAD

View full text Add to dashboard Cite

show abstract

“…Osteomyelitis is relatively uncommon in the jaws [ 9 ]. Actinomyces israelii is the main cause of neck and face actinomycosis.…”

Section: Discussionmentioning

confidence: 99%

“…After omitting repetitions, mandibular cases, and reports of osteomyelitis without actinomycosis, we found 11 articles that presented 13 cases ( Table 1 ) [ 3 , 6 , 7 , 9 - 16 ], of which, only 4 were men [ 6 , 9 , 11 , 12 ] and two were in the 5 th and 6 th decades of life [ 6 , 9 ]. To the best of our knowledge, this is the first time that phenytoin has been proposed as a risk factor for this condition.…”

Section: Case Reportmentioning

confidence: 99%

Actinomycotic Osteomyelitis of the Maxilla in a Patient on Phenytoin

Agha‐Hosseini¹,

Hoseini²,

Mahdavi³

2022

fid

View full text Add to dashboard Cite

Actinomycosis is caused by Actinomyces species and is relatively rare in humans. Because of the special collateral blood flow, osteomyelitis is less common in the maxilla than the mandible. Although there are few case reports for jaw osteomyelitis, actinomycotic osteomyelitis associated with phenytoin therapy has not been reported before. The data show that antiepileptic drugs induce suppression of the immune system. This report presents a rare case of a 58-year-old man on phenytoin with actinomycotic osteomyelitis, and reviews the relevant literature.

show abstract

“…Bone involvement by Actinomyces is rare, usually representing a secondary infection. Primary bone infection by actinomyces, actinomycotic osteomyelitis, has been rarely reported in jaws and can occur in immunocompromised patients (Gannepalli et al, 2015;Sezer et al, 2017;Agarwal et al, 2019). Actinomycotic osteomyelitis is more common in the mandible than in the maxilla, possibly due the higher vascularization of the last (Crossman & Herold, 2009;Gannepalli et al, 2015).…”

Section: Introductionmentioning

confidence: 99%

Actinomycotic Osteomyelitis and Myiasis in Oroantral Communication: Clinicopathological and Tomographic Findings

Faé

Sant'Ana

Mariz

et al. 2022

Int. J. Odontostomat.

View full text Add to dashboard Cite

Actinomycotic osteomyelitis of the maxilla presenting with oroantral communication is very rare, herein we report the first case of this condition in association with myiasis. A 50-year-old man reported chronic sinusopathy and a non-healing maxillary lesion, with 30 years of evolution, presenting occasional nasal and intraoral purulent discharge, with foul smell, and recurrent episodes of larvae presence. Cone beam computed tomography showed a large hyperdense image inside the left maxillary sinus, with focal areas with soft tissue density, and extensive discontinuity of the maxillary sinus floor, confirming the oroantral fistula. The necrotic tissue curetted during surgery presented hard consistency, and dark greenish color, and was submitted for histopathological analysis. Microscopically, necrotic bone, masses of filamentous bacteria colonies, compatible with actinomycosis, and large rhomboidal structures surrounded by eosinophilic capsule -suggestive of larvae, were observed. The diagnosis of actinomycotic osteomyelitis with presence of structures compatible with larvae was established.

show abstract

Palatal actinomycosis osteomyelitis–Complication of impacted tooth in a diabetic

Cited by 5 publications

References 11 publications

Medication-induced osteonecrosis of the maxilla, potentiated by fungical infection: Case report

Medication-induced osteonecrosis of the maxilla, potentiated by fungical infection: Case report

Actinomycotic Osteomyelitis of the Maxilla in a Patient on Phenytoin

Actinomycotic Osteomyelitis and Myiasis in Oroantral Communication: Clinicopathological and Tomographic Findings

Contact Info

Product

Resources

About